Effects of taVNS on Fibromyalgia Pain
Part of paid clinical trials in Cambridge, Massachusetts.
- Sponsor
- Spaulding Rehabilitation Hospital
- Study ID
- NCT06193317
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Fibromyalgia, Pain
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Transauricular vagus nerve stimulation (taVNS) — DEVICETransauricular vagus nerve stimulation (taVNS) is a simple technique in which small surface electrodes are placed over the skin of the ear that are thought to be innervated by the auricular branch of the vagus nerve (ABVN).
Study Details
Transauricular vagus nerve stimulation (taVNS) is a newer delivery system, using a non-invasive stimulation device placed at the ear's concha. TaVNS is a portable, safe, and low-cost intervention, and according to some studies, taVNS may influence nociception and pain perception, which can lead to potential applications for various painful illnesses, including fibromyalgia (FM). This trial aims to investigate the clinical effects of taVNS on pain control in FM subjects.
Key Dates
- Start date
- Jun 1, 2026
- Status verified
- Sep 2025
- Primary completion
- May 1, 2028
- Completion
- May 1, 2029
Study Design
- Enrollment
- 152 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Active taVNSTaVNS will be administered by an earset, with conductive eartips placed on the auricular concha of the ears, connected to a stimulator, and during active stimulation, we stimulate both the cymba conchae and external auditory canal of both left and right ears with the following parameters: 30Hertz (Hz), 200-250 us, and with adjustable intensity for 60 min for 16 sessions.
- Sham Comparator: Sham taVNSSham condition will have the same device, with an earset, and conductive eartips placed in the same location of the active stimulation; however during 60 min for 16 sessions there will be no current and the device will be turned off.
Primary Outcome Measure
pain severity using the Brief Pain Inventory (BPI pain) [ Time Frame: From Baseline to Visit 19 (at 4 weeks) ]
Central Contacts
- Felipe Fregni, MD, PhD, MPH617 952 6158
- Elly Pichardo, MD617 952 6154
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Spaulding Hospital Cambridge | Cambridge | Massachusetts | 02138 | - |